ELVN
Enliven Therapeutics, Inc.
Set alert
44.25 USD -0.83 -1.84%
44.09 Day range 45.87
15.14 52-week range 61.15
- YTD
- +187.34%
- 1 year
- +84.61%
- Open
- 44.92
- Prev close
- 45.08
- Mkt cap
- 3.24B
- Vol
- 1.24M
- Avg vol
- 1.35M
- EPS
- -1.67
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 44.09
- High
- 45.87
- Forward P/E
- -19.10
- Beta
- 0.34
- Short ratio
- 5.98
- Inst. own
- 115.69%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 49.00
- 200-d avg
- 42.64
- 1y target
- 74.42
1Y chart
Closing price and volume
Compare ELVN
Chart and line up ELVN against other symbols or a saved comparison set.
- ELVN Enliven Therapeutics, Inc.
44.25
-0.83 -1.84%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | ELVN | SPY | QQQ |
|---|---|---|---|
| Last price | 44.25 | 755.72 | 690.49 |
| Change | -0.83 | -13.64 | -24.85 |
| Change % | -1.84% | -1.77% | -3.47% |
| Open | 44.92 | 761.38 | 697.13 |
| Day high | 45.87 | 761.46 | 698.63 |
| Day low | 44.09 | 750.36 | 683.45 |
| Previous close | 45.08 | 769.36 | 715.34 |
| Volume | 1.24M | 77.70M | 85.24M |
| Average volume | 1.35M | 41.22M | 34.57M |
| Market cap | 3.24B | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -1.67 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 61.15 | 779.09 | 759.66 |
| 52-week low | 15.14 | 631.97 | 558.28 |
| 1-week return | +6.58% | -0.559233% | -1.97% |
| 1-month return | -3.47% | -0.906075% | -6.66% |
| 3-month return | -17.98% | +1.89% | +1.02% |
| 6-month return | +7.32% | +5.16% | +3.41% |
| Year-to-date return | +187.34% | +10.82% | +12.40% |
| 1-year return | +84.61% | +11.16% | +10.29% |
| 2-year return | +58.89% | +32.90% | +42.71% |
| 50-day moving average | 49.00 | 767.63 | 725.41 |
| 200-day moving average | 42.64 | 728.53 | 679.17 |
| Target price | 74.42 | — | — |
| Beta | 0.337 | 0.00 | 0.00 |
| Short ratio | 5.98 | — | — |
| Institutional ownership | 115.69% | — | — |